Bob Mehr

Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada.

Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada.

Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada.

Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada.

Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada.

Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada.